期刊论文详细信息
Molecular Therapy: Nucleic Acids
CD4+ T Cells Modified by the Endoribonuclease MazF Are Safe and Can Persist in SHIV-infected Rhesus Macaques
Junichi Mineno1  Naoki Saito1  Hideto Chono1  Hiroaki Shibata2  Yasuhiro Yasutomi2  Naohide Ageyama2 
[1] Center for Cell and Gene Therapy, Takara Bio Inc, Seta, Otsu, Shiga, Japan;Tsukuba Primate Research Center, National Institute of Biomedical Innovation, Tsukuba, Ibaraki, Japan;
关键词: gene therapy;    HIV-1;    MazF;    primate model;    rhesus macaque;    retroviral vector;    SHIV;   
DOI  :  10.1038/mtna.2014.20
来源: DOAJ
【 摘 要 】

MazF, an endoribonuclease encoded by Escherichia coli, specifically cleaves the ACA (adenine–cytosine–adenine) sequence of single-stranded RNAs. Conditional expression of MazF under the control of the HIV-1 LTR promoter rendered CD4+ T cells resistant to HIV-1 replication without affecting cell growth. To investigate the safety, persistence and efficacy of MazF-modified CD4+ T cells in a nonhuman primate model in vivo, rhesus macaques were infected with a pathogenic simian/human immunodeficiency virus (SHIV) and transplanted with autologous MazF-modified CD4+ T cells. MazF-modified CD4+ T cells were clearly detected throughout the experimental period of more than 6 months. The CD4+ T cell count values increased in all four rhesus macaques. Moreover, the transplantation of the MazF-modified CD4+ T cells was not immunogenic, and did not elicit cellular or humoral immune responses. These data suggest that the autologous transplantation of MazF-modified CD4+ T cells in the presence of SHIV is effective, safe and not immunogenic, indicating that this is an attractive strategy for HIV-1 gene therapy.

【 授权许可】

Unknown   

  文献评价指标  
  下载次数:0次 浏览次数:1次